G. Witzke

发表

Shortened Activated Partial Thromboplastin Time May Help in Diagnosing Hereditary and Acquired Angioedema

K. Bork, G. Witzke, 2016, International Archives of Allergy and Immunology.

Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.

K. Bork, J. Hardt, G. Witzke, 2012, The Journal of allergy and clinical immunology.

Hereditary angioedema with normal C1‐INH with versus without specific F12 gene mutations

K. Bork, K. Wulff, J. Hardt, 2015, Allergy.

High exhaled nitric oxide levels correlate with nonadherence in acute asthmatic children

S. Boor, K. Bork, R. Brehler, 2017 .

Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency.

K. Bork, G. Witzke, Konrad Bork, 1989, The Journal of allergy and clinical immunology.

A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor.

K. Bork, K. Wulff, P. Meinke, 2011, Clinical immunology.

Hereditary angioneurotic oedema and blood-coagulation: Interaction between C1-esterase-inhibitor and the activation factors of the proteolytic enzyme systems

K. Bork, P. Beneš, G. Witzke, 1983, Klinische Wochenschrift.

Hereditary angioedema with a mutation in the plasminogen gene

I. Braenne, K. Bork, K. Wulff, 2018, Allergy.

Stability of Beriplast P fibrin sealant: storage and reconstitution.

G. Witzke, M. Broder, U. Eberhard, 2006, International journal of pharmaceutics.

A comparison of fibrin sealants in relation to their in vitro and in vivo properties.

Thomas Pfeifer, H. Metzner, T. Pfeifer, 2003, Thrombosis research.

Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy.

K. Bork, K. Wulff, P. Staubach, 2009, The Journal of allergy and clinical immunology.

Blindness, tetraspasticity, and other signs of irreversible brain damage in hereditary angioedema.

S. Boor, K. Bork, R. Brehler, 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Kallikrein–kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys

K. Bork, J. Hardt, G. Witzke, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N‐terminal cleavage site of bradykinin

I. Braenne, H. Rossmann, K. Bork, 2019, Allergy.

Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses

M. Reitz, P. Gutjahr, R. Egbring, 1984, Klinische Wochenschrift.

[Hereditary angioneurotic edema. Clinical aspects and extended diagnostic and therapeutic possibilities].

K. Bork, G. Witzke, 1979, Deutsche medizinische Wochenschrift.

Treatment for hereditary angioedema with normal C1‐INH and specific mutations in the F12 gene (HAE‐FXII)

K. Bork, K. Wulff, J. Hardt, 2017, Allergy.

Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation.

Britta S. Möhl, K. Bork, K. Wulff, 2021, The Journal of allergy and clinical immunology.

Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor

K. Bork, K. Wulff, P. Lohse, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Antihistamine-resistant angioedema in women with negative family history: estrogens and F12 gene mutations.

K. Bork, K. Wulff, P. Lohse, 2013, The American journal of medicine.

Interaction between $$C\bar 1$$ -INA, coagulation, fibrinolysis and kinin system in hereditary angioneurotic edema (HANE) and urticaria

K. Bork, W. Kreuz, G. Witzke, 2004, Archives of Dermatological Research.

[Hereditary angioneurotic edema. Clinical picture, diagnosis, patient management and drug therapy].

K. Bork, W. Kreuz, G. Witzke, 2008, Deutsche medizinische Wochenschrift.

On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema

I. Braenne, K. Bork, K. Wulff, 2018, Allergy.

Tamoxifen may cause life‐threatening angioedema attacks in patients with hereditary angioedema

K. Bork, K. Wulff, J. Hardt, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Metabolism of radioactive-labeled fat emulsions in the postoperative and posttraumatic period.

G. Tempel, J. Eckart, P. Schürnbrand, 1973, The American journal of clinical nutrition.

Blindness, tetraspasticity, and other signs of irreversible brain damage in hereditary angioedema.

S. Boor, K. Bork, R. Brehler, 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy.

K. Bork, K. Wulff, P. Staubach, 2009, The Journal of allergy and clinical immunology.